Farrar W E, Gramling P K
J Infect Dis. 1976 Jun;133(6):691-5. doi: 10.1093/infdis/133.6.691.
Four newer cephalosporins (cefazolin, cefamandole, SK&F 59962, and cefoxitin) were investigated for determination of their antistaphylococcal activity and relative stability to staphylococcal beta-lactamase (penicillinase). Crude preparations of beta-lactamase from recent clinical isolates of Staphylococcus aureus were used. Cefamandole and SK&F 59962 were highly active against both large and small inocula of staphylococci and were resistant to staphylococcal beta-lactamase. Cefoxitin, although resistant to beta-lactamase, possessed less antibacterial potency but was still approximately as active as methicillin. Cefazolin was somewhat more susceptible to staphylococcal beta-lactamase than the other three agents and resembled cephaloridine in this respect. With minor exceptions, a correlation was found between the susceptibility of different agents to beta-lactamase and the magnitude of the effect of inoculum size when the drugs were tested against large and small inocula of staphylococci.
研究了四种新型头孢菌素(头孢唑林、头孢孟多、SK&F 59962和头孢西丁)的抗葡萄球菌活性及其对葡萄球菌β-内酰胺酶(青霉素酶)的相对稳定性。使用了从近期金黄色葡萄球菌临床分离株中提取的β-内酰胺酶粗制品。头孢孟多和SK&F 59962对葡萄球菌的大接种量和小接种量均具有高度活性,并且对葡萄球菌β-内酰胺酶具有抗性。头孢西丁虽然对β-内酰胺酶具有抗性,但其抗菌效力较低,但仍与甲氧西林的活性大致相当。头孢唑林比其他三种药物对葡萄球菌β-内酰胺酶更敏感,在这方面与头孢噻啶相似。除了一些小的例外情况,当用这些药物对葡萄球菌的大接种量和小接种量进行测试时,发现不同药物对β-内酰胺酶的敏感性与接种量大小的影响程度之间存在相关性。